Our results suggest that, in BRAFWT melanomas, increases in CXCR3 signaling mediates increases in IL-8 expression, and consequently, that CXCR3 may contribute to the transition from RGP to VGP in the melanoma patient population where the BRAFV600E mutation is not present. This evidence concerns the gene CXCL8 and melanoma.